Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Safety and Efficacy of Atrasentan in Men With Hormone Naive Prostate Cancer Exhibiting Early Signs of Biochemical Failure

ClinicalTrials.gov ID: NCT00038662

Public ClinicalTrials.gov record NCT00038662. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 29, 2026, 7:29 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2 Study Evaluating the Safety and Efficacy of Atrasentan (ABT-627) in Men With Hormone Naive Prostate Cancer Exhibiting Early Signs of Biochemical Failure

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this phase II, randomized, double-blind placebo controlled, multi-center study is to evaluate the safety and efficacy of 10 mg atrasentan in hormone naive subjects as measured by rate of rise in the PSA (primary objective).

Study identification

NCT ID
NCT00038662
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Abbott
Industry
Enrollment
200 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
19 Years and older
Sex
Male
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 2002 (Type not available)
Primary completion
Not listed
Completion
Not listed
Last update posted
Aug 15, 2006

Started 2002

United States locations

U.S. sites
24
U.S. states
17
U.S. cities
22
Facility City State ZIP Site status
Urology Centers Of Alabama Homewood Alabama 35205 —
Alaska Clinical Research Center, LLC Anchorage Alaska 99508 —
Arkansas Urologial Associates, PA Little Rock Arkansas 72205 —
San Diego Urology Center La Mesa California 91942 —
Western Clinical Research Inc Torrance California 90505 —
Georgetown University Medical Center Washington D.C. District of Columbia 20007 —
Clinical Physiology Associates Fort Myers Florida 33916 —
Southeastern Urological Center, PA Tallahassee Florida 32308 —
Northwestern University Chicago Illinois 60611 —
Johns Hopkins Oncology Center Baltimore Maryland 21231-1000 —
Sheldon Freedman MD Las Vegas Nevada 89109 —
VA Medical Center(111) Reno Nevada 89502 —
Nevada Urology Associates Reno Nevada 89511 —
Carolinas Medical Centre Charlotte North Carolina 28204 —
Cleveland Clinic Foundation Cleveland Ohio 44195 —
Urologic Specialists Of Oklahoma, Inc. Tulsa Oklahoma 74104-5433 —
Oregon Urology Specialists Eugene Oregon 97401 —
Urological Assoc. of Lancaster Lancaster Pennsylvania 17604-3200 —
University Of Pittsburgh Pittsburgh Pennsylvania 15232 —
Center for Urologic Care West Reading Pennsylvania 19611 —
Ntouch Research Corporation Dallas Texas 75230 —
Salt Lake Research Salt Lake City Utah 84124 —
Jeffrey Frankel, M.D. Seattle Washington 98166-3059 —
University of Washington Medical Center Seattle Washington 98195 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 16 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00038662, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 15, 2006 · Synced Oct 29, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00038662 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →